Ex-Energy & Commerce GOP Chair Walden Launches Lobbying Firm

Former House E&C GOP Chair Greg Walden (Ore.) has set up a public policy and political strategy firm in partnership with one of Washington’s top lobbying firms. | C-SPAN

Greg Walden (Ore.), the former Republican chair of the U.S. House Energy and Commerce (E&C) Committee, yesterday launched his own public policy and political strategy firm in partnership with one of Washington’s top lobbying firms.

Walden and the Alpine Group

Read More »

HRSA Allows 340B Enrollment Flexibility in Storm-Battered Texas

A Feb. 13-17 winter storm caused mass power outages and water and food shortages in Texas.

The U.S. Health Resources and Services Administration (HRSA), in light of the declared public health emergency in Texas, is letting eligible health care providers there enroll immediately in the 340B drug pricing program instead of waiting for the next normal

Read More »

AEH Asks Biden to Prioritize Three 340B-Related Issues

America's Essential Hospitals wants the Biden administration to reverse Trump administration policies that its says harm and the 340B program and are contrary to congressional intent. | Facebook

The Biden administration should reverse “harmful Trump administration policies” that “undermined the 340B program and contravened Congress’ intent,” the group America’s Essential Hospitals advised President Biden in a letter earlier this month.

America’s Essential Hospitals’ Feb. 10 letter said

Read More »

Biden Will Turn to Drug Pricing Once COVID-19 Ebbs, Shalala Predicts

Former HHS Secretary Donna Shalala (right) holds her rescue dog, Fauci, at the end of her talk yesterday during the 340B Coalition winter conference.

President Biden will likely turn to lowering drug prices once the COVID-19 pandemic stops demanding so much of his attention, Donna Shalala, U.S. Health and Human Services (HHS) Secretary during both of President Clinton’s terms in office, predicted in a

Read More »

CBO Says Lifting Medicaid Drug Rebate Cap Would Save $16 Billion

Eliminating the cap on rebates that drug manufacturers pay to Medicaid would save Medicaid about $16 billion over 10 years, the CBO estimates.

The U.S. Congressional Budget Office (CBO) estimates that eliminating the limit on rebates that drug manufacturers pay to Medicaid, now capped at 100 percent of a drug’s average manufacturer price (AMP), “would reduce direct spending in Medicaid by $15.9 billion

Read More »

Senate Hearings Next Week on Becerra’s Nomination to Head HHS

The Senate Finance and HELP committees will hold hearings next week on Xavier Becerra's nomination to serve as HHS Secretary.

Two U.S. Senate committees have scheduled hearings next week on President Biden’s nomination of California Attorney General Xavier Becerra to be the next U.S. Health and Human Services (HHS) Secretary. In December, Becerra helped spearhead a bipartisan letter of

Read More »

Biden Reportedly Has Settled on His Choice to Run CMS

President Biden reportedly has chosen former federal executive and legislative branch health policy official Chiquita Brooks-LaSure to be his nominee to head CMS.

Several news organizations report that the Biden administration will nominate former federal executive and legislative branch health policy official Chiquita Brooks-LaSure to serve as Administrator of the Center for Medicare & Medicaid Services (CMS). The White House had not announced

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report